Adapting to Change
Federal Policy Dynamics and the Pharmaceutical Industry
Samenvatting
The US pharmaceutical landscape is in the midst of impactful shifts. In this analysis, a federal policy expert unpacks the complex forces reshaping how life-saving therapies are researched, developed, manufactured, and delivered.

